诊断学理论与实践 ›› 2025, Vol. 24 ›› Issue (01): 1-6.doi: 10.16150/j.1671-2870.2025.01.001
宁光
收稿日期:
2024-11-08
接受日期:
2025-01-24
出版日期:
2025-02-25
发布日期:
2025-02-25
基金资助:
NING Guang
Received:
2024-11-08
Accepted:
2025-01-24
Published:
2025-02-25
Online:
2025-02-25
摘要:
糖尿病已成为全球重大的公共卫生问题。截至2021年,我国约有1.41亿例糖尿病患者,是世界上糖尿病患者人数最多的国家,其中未能确诊者占三分之二,这一现状给糖尿病及其并发症的防控工作带来严峻挑战。为应对这些挑战,所制定的策略不但要全面,还需要开展多部门合作的全面预防策略,包括全民初级预防、高危人群一级预防和糖尿病患者二级预防。针对全民,应通过健康教育、政策引导和技术资源支持,推广健康生活方式;针对高危人群,应强调糖尿病筛查的重要性,并采取生活方式干预和药物治疗相结合的措施;对于糖尿病患者,应重点进行心血管并发症的泛危险因素监测和管理。我国开发的全新糖尿病管理模式——国家标准化代谢性疾病管理中心,通过为网络内医生提供结构化的培训和教育,推行糖尿病管理标准化、一站式的解决方案,减少了不同区域间的糖尿病管理差异,有效提高了对糖尿病及其并发症的诊断和治疗效率。为实现“健康中国2030”行动计划目标,需要政府、部门、社区和个人等多方面的共同努力,提高糖尿病的知晓率、规范化管理覆盖率、治疗率和控制率,降低糖尿病及其并发症的发生,为提高民众健康水平,共建共享健康中国奠定重要基础。
中图分类号:
宁光. 中国糖尿病的防控现状与挑战[J]. 诊断学理论与实践, 2025, 24(01): 1-6.
NING Guang. Current situation and challenges of prevention and control of diabetes in China[J]. Journal of Diagnostics Concepts & Practice, 2025, 24(01): 1-6.
[1] |
XU Y, WANG L, HE J,et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9):948-959.
doi: 10.1001/jama.2013.168118 pmid: 24002281 |
[2] | 健康中国行动推进委员会. 健康中国行动(2019-2030)[EB/OL]. 2019. https://www.gov.cnxinwen2019-0715content_5409694.htm. |
Healthy China Initiative Promotion Committee. Healthy China Initiative (2019–2030)[EB/OL]. 2019. https://www.gov.cnxinwen2019-0715content_5409694.htm. | |
[3] | LIU J, LIU M, CHAI Z,et al. Projected rapid growth in diabetes disease burden and economic burden in China: a spatio-temporal study from 2020 to 2030[J]. Lancet Reg Health West Pac, 2023, 33:100700. |
[4] | SUN H, SAEEDI P, KARURANGA S,et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183:109119. |
[5] | PENG W, CHEN S, CHEN X,et al. Trends in major non-communicable diseases and related risk factors in China 2002-2019: an analysis of nationally representative survey data[J]. Lancet Reg Health West Pac, 2023, 43:100809. |
[6] |
ZHAO Z, LI M, LI C,et al. Dietary preferences and diabetic risk in China: A large-scale nationwide Internet data-based study[J]. J Diabetes, 2020, 12(4):270-278.
doi: 10.1111/1753-0407.12967 pmid: 31290214 |
[7] | WU W, ZHANG J W, LI Y,et al. Population-based prevalence of self-reported pediatric diabetes and screening for undiagnosed type 2 diabetes in Chinese children in years 2017-2019, a cross-sectional study[J]. Lancet Reg Health West Pac, 2024, 52:101206. |
[8] |
YUAN C, DONG Y, CHEN H,et al. Determinants of childhood obesity in China[J]. Lancet Public Health, 2024, 9(12):e1105-e1114.
doi: 10.1016/S2468-2667(24)00246-9 pmid: 39579777 |
[9] | XIE J, WANG M, LONG Z,et al. Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019[J]. BMJ, 2022, 379:e072385. |
[10] | YEUNG R O, ZHANG Y, LUK A,et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort[J]. Lancet Diabetes Endocrinol, 2014, 2(12):935-943. |
[11] |
KE C, LAU E, SHAH B R,et al. Excess Burden of Mental Illness and Hospitalization in Young-Onset Type 2 Diabetes: A Population-Based Cohort Study[J]. Ann Intern Med, 2019, 170(3):145-154.
doi: 10.7326/M18-1900 pmid: 30641547 |
[12] |
BRAGG F, HOLMES M V, IONA A,et al. Association between diabetes and cause-specific mortality in rural and urban areas of China[J]. JAMA, 2017, 317(3):280-289.
doi: 10.1001/jama.2016.19720 pmid: 28114552 |
[13] | LU J, XU Y, BI Y,et al. Reducing inequity through tackling social determinants of cardiovascular diseases in China[J]. BMJ, 2024, 387:e079197. |
[14] |
LI H, KHOR C C, FAN J,et al. Genetic risk, adherence to a healthy lifestyle, and type 2 diabetes risk among 550,000 Chinese adults: results from 2 independent Asian cohorts[J]. Am J Clin Nutr, 2020, 111(3):698-707.
doi: 10.1093/ajcn/nqz310 pmid: 31974579 |
[15] |
LI M, XU Y, WAN Q,et al. Individual and combined associations of modifiable lifestyle and metabolic health status with new-onset diabetes and major cardiovascular events: the china cardiometabolic disease and cancer cohort (4c) study[J]. Diabetes Care, 2020, 43(8):1929-1936.
doi: 10.2337/dc20-0256 pmid: 32540923 |
[16] |
WANG Y, FENG L, ZENG G,et al. Effects of cuisine-based chinese Heart-Healthy Diet in lowering blood pressure among adults in china: multicenter, single-blind, randomized, parallel controlled feeding trial[J]. Circulation, 2022, 146(4):303-315.
doi: 10.1161/CIRCULATIONAHA.122.059045 pmid: 35861850 |
[17] |
WANG J, LIN X, BLOOMGARDEN Z T,et al. The Jiangnan diet, a healthy diet pattern for Chinese[J]. J Diabetes, 2020, 12(5):365-371.
doi: 10.1111/1753-0407.13015 pmid: 31846221 |
[18] | 中国营养学会. 中国居民膳食指南(2022)[R/OL]. 2022. http://dg.cnsoc.org/index.html. |
Chinese Nutrition Society. Dietary guidelines for Chinese residents(2022)[R/OL]. 2022.http://dg.cnsoc.org/index.html. | |
[19] | LI N, YE Q, DENG Q,et al. Physical activity intervention for leisure-time activity levels among older adults: A cluster randomized trial[J]. JAMA Netw Open, 2023, 6(9):e2333195. |
[20] | WANG H, BLAKE H, CHATTOPADHYAY K. School-based behaviour change intervention to increase physical activity levels among children: a feasibility cluster non-randomised controlled trial in Yangzhou, China[J]. BMJ Open, 2021, 11(10):e052659. |
[21] |
CHAN K H, XIAO D, ZHOU M,et al. Tobacco control in China[J]. Lancet Public Health, 2023, 8(12):e1006-e1015.
doi: 10.1016/S2468-2667(23)00242-6 pmid: 38000880 |
[22] | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4):311-398. |
Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) [J]. Chin J Endocrinol Metab, 2021, 37(4):311-398. | |
[23] | LU J, HE J, LI M,et al. Predictive value of fasting glucose, postload glucose, and hemoglobin A1c on risk of diabetes and complications in Chinese adults[J]. Diabetes Care, 2019, 42(8):1539-1548. |
[24] |
WU J, HOU X, CHEN L,et al. Development and validation of a non-invasive assessment tool for screening prevalent undiagnosed diabetes in middle-aged and elderly Chinese[J]. Prev Med, 2019, 119:145-152.
doi: S0091-7435(18)30404-3 pmid: 30594538 |
[25] |
ZHOU X, QIAO Q, JI L,et al. Nonlaboratory-based risk assessment algorithm for undiagnosed type 2 diabetes developed on a nation-wide diabetes survey[J]. Diabetes Care, 2013, 36(12):3944-3952.
doi: 10.2337/dc13-0593 pmid: 24144651 |
[26] |
PAN X R, LI G W, HU Y H,et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study[J]. Diabetes Care, 1997, 20(4):537-544.
doi: 10.2337/diacare.20.4.537 pmid: 9096977 |
[27] | GONG Q, ZHANG P, WANG J,et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study[J]. Lancet Diabetes Endocrinol, 2019, 7(6):452-461. |
[28] | HOLMAN R R, COLEMAN R L, CHAN J C N,et al. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial[J]. Lancet Diabetes Endocrinol, 2017, 5(11):877-886. |
[29] | ZHANG L, ZHANG Y, SHEN S,et al. Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial[J]. Lancet Diabetes Endocrinol, 2023, 11(8):567-577. |
[30] | ZHENG R, XU Y, LI M,et al. Pan-risk factor for a comprehensive cardiovascular health management[J]. J Diabetes, 2022, 14(3):179-191. |
[31] |
WANG T, LU J, SU Q,et al. Ideal cardiovascular health metrics and major cardiovascular events in patients with prediabetes and diabetes[J]. JAMA Cardiol, 2019, 4(9):874-883.
doi: 10.1001/jamacardio.2019.2499 pmid: 31365039 |
[32] | BI Y, LI M, LIU Y,et al. Intensive blood-pressure control in patients with type 2 diabetes[J]. N Engl J Med, 2025, 392(12):1155-1167. |
[33] | 代谢中心学术委员会, 代谢中心专家顾问委员会, 代谢中心理事会, 等. 国家标准化代谢性疾病管理中心(MMC)代谢病管理指南(第二版)[J]. 中华内分泌代谢杂志, 2023, 39(6):538-554. |
Academic Committee of Metabolic Management Center, Expert Advisory Committee of Metabolic Management Center, Council of Metabolic Management Center,et al. Metabolic disease management guideline for National Metabolic Management Center(2nd edition)[J]. Chin J Endocrinol Metab, 2023, 39(6):538-554. | |
[34] |
RAZ I. MMC celebrating 6 years of experience and expansion[J]. J Diabetes, 2022, 14(5):356-357.
doi: 10.1111/1753-0407.13270 pmid: 35545818 |
[35] | 国家卫生健康委. 健康中国行动——糖尿病防治行动实施方案(2024—2030年)[EB/OL]. 2024. https://www.gov.cn/zhengce/zhengceku/202407/content_6965000.htm. |
National Health Commission. Healthy China Initiative:Implementation plan of diabetes prevention and control action(2024-2030)[EB/OL]. 2024.https://www.gov.cn/zhengce/zhengceku/202407/content_6965000.htm. |
[1] | 张珂, 张唯一, 孙海天, 曹铭峰, 张新焕. 细胞失巢相关基因PDK4与2型糖尿病发病相关——基于生物信息的研究[J]. 诊断学理论与实践, 2025, 24(01): 27-34. |
[2] | 雷朝闻尉, 饶佳玲, 周梦雪, 杨虹. 胰腺脂肪沉积的危险因素及相关疾病的研究进展[J]. 诊断学理论与实践, 2025, 24(01): 72-79. |
[3] | 何翠环, 石德荣, 孙丹丹, 李育蕊, 夏广昊. 胰高血糖素样肽1受体激动剂在糖尿病视网膜病变中的作用机制研究进展[J]. 诊断学理论与实践, 2025, 24(01): 80-88. |
[4] | 邹慧敏, 王遂军. 中国糖尿病诊断标准演变及特殊人群血糖管理[J]. 诊断学理论与实践, 2025, 24(01): 14-20. |
[5] | 裴舟, 罗飞宏. 中国儿童糖尿病诊治进展[J]. 诊断学理论与实践, 2024, 23(05): 461-466. |
[6] | 李延兵. 2024年美国糖尿病学会《糖尿病诊疗标准》解读——糖尿病诊断和分型[J]. 诊断学理论与实践, 2024, 23(05): 467-473. |
[7] | 缪婕, 王巍, 赵雅洁, 张凤如, 沈琳辉. 老年男性2型糖尿病患者游离三碘甲状腺原氨酸水平与左心室舒张功能不全相关[J]. 诊断学理论与实践, 2024, 23(02): 155-161. |
[8] | 周思锋, 朱洁云, 徐海舒, 倪瑛. 色素上皮衍生因子在糖尿病视网膜病变中的作用机制研究进展[J]. 诊断学理论与实践, 2024, 23(02): 192-201. |
[9] | 张琼, 吴彦霖, 胡起维, 张泽伟, 黄守约. 光学相干断层扫描血管成像参数诊断非增殖性糖尿病视网膜病变的价值分析[J]. 诊断学理论与实践, 2024, 23(01): 67-76. |
[10] | 丁永杰, 张柳, 李庆云. 肿瘤相关静脉血栓栓塞症的防治新认识[J]. 诊断学理论与实践, 2023, 22(04): 323-331. |
[11] | 巴福华, 钟鸣, 陈影, 陈尔真. 再喂养综合征的临床防治进展[J]. 诊断学理论与实践, 2023, 22(01): 80-84. |
[12] | 中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下糖尿病管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 136-138. |
[13] | 张祎博, 吴文娟, 毕宇芳, 景峰, 顾志冬, 杨之涛, 尚寒冰, 林靖生, 陈尔真. 大型方舱医院感染预防与控制体系的建设和实践探索[J]. 诊断学理论与实践, 2022, 21(02): 165-168. |
[14] | 庄蕾, 高卫益. 新型冠状病毒肺炎疫情期间非定点医疗机构“分区管理”策略[J]. 诊断学理论与实践, 2022, 21(02): 245-247. |
[15] | 王亦晨, 周剑平, 杨振华, 王敏慧, 刘佳, 倪语星, 张祎博, 石大可, 徐玉敏. 新型冠状病毒肺炎救治临时定点医院工作人员医院感染防控管理方案[J]. 诊断学理论与实践, 2022, 21(02): 270-272. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||